Scientists have found that those living with obstructive sleep apnea (OSA) have a 71 per cent higher risk of cardiovascular events (CVEs) or death from any cause (all-cause mortality) compared with those not living with OSA. 

New research, to be presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, May 12-15), is a collaboration between Imperial College Health Partners; Imperial College Healthcare NHS Trust, London, UK; and Eli Lilly and Company (Lilly).